Moving Forward™ Patient Support Guide

The first step to help manage Parkinson's disease (PD) is to arm yourself with knowledge about the disease and your treatment options.

As a company dedicated to the development of innovative treatments, Teva Neuroscience has developed Moving Forward™, a guide for people with Parkinson’s disease designed to help manage all aspects of life with the condition.

We recognize that Parkinson's disease affects each person differently, so this guide is intended as a roadmap to point you in the direction of resources to meet your personal needs with topics such as:

  • Symptoms and progression
  • Options for drug therapy
  • Managing the disease and your treatment
  • Patient advocacy and activism
  • Information for caregivers

Sign up to receive this free, informational guide. It is available for immediate download, so you can read the guide on-screen, save it to your computer for easy access, or print it out to read later. We hope you find the Moving Forward™ patient resource guide to be a helpful tool, and that it inspires you to make a lifelong commitment to taking an active role in the management of your Parkinson's disease.

Click here to view, download, and print the Moving Forward™ Patient Resource Guide.
 (Please note, due to the size of the guide, it could take up to several minutes to download depending upon the speed of your internet connection.)

To view this document, you will need Adobe® Reader®. For a FREE download of Adobe® Reader®, click here.

Moving Forward™ is a trademark of Teva Neuroscience, Inc.


AZL101023742/101221

 

AZILECT (rasagiline tablets) is indicated for the treatment of the signs and symptoms of Parkinson’s disease (PD) both as initial therapy alone and to be added to levodopa later in the disease.

IMPORTANT SAFETY INFORMATION ABOUT AZILECT

Do not take Azilect if you are taking meperidine as it could result in a serious reaction such as coma or death. Also, do not take Azilect with tramadol, methadone, propoxyphene, dextromethophran, St. John’s wort, or cyclobenzaprine. You also should not take Azilect with other monoamine oxidase inhibitors (MAOIs).

Inform your physician if you are taking, or planning to take, any prescription or over-the-counter drugs, especially antidepressants and ciprofloxacin. If you have moderate to severe liver disease, you should not take Azilect. You should not exceed a dose of 1 mg per day of Azilect in order to prevent a possibly dangerous increase in blood pressure. All PD patients should be monitored for melanoma (skin cancer) on a regular basis.

Side effects seen with Azilect alone are flu syndrome, joint pain, depression, and indigestion: and when taken with levodopa are uncontrolled movements (dyskinesia), accidental injury, weight loss, low blood pressure when standing, vomiting, anorexia, joint pain, abdominal pain, nausea, constipation, dry mouth, rash, abnormal dreams, and fall.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

AZL101023709/101191